Cromolyn sodium Inh Soln Rx
Generic Name and Formulations:
Cromolyn sodium 20mg/2mL; soln for inhalation.
Various generic manufacturers
Indications for Cromolyn sodium Inh Soln:
Asthma prophylaxis. Prevention of bronchoconstriction before exposure to a known precipitant (eg, exercise).
Adults and Children:
<2 years: not recommended. ≥2 years: 20mg administered by power-operated nebulizer 4 times a day. Bronchoconstriction prevention: contents of 1 amp inhaled up to 60 minutes before precipitant.
Not for treatment of acute attack. Impaired renal or hepatic function: reduce dose. Reevaluate if no improvement after 4 weeks. Avoid abrupt cessation. Discontinue if eosinophilic pneumonia occurs. Coronary artery disease or arrhythmias (Inhaler). Pregnancy (Cat.B). Nursing mothers.
Mast cell stabilizer.
Avoid use with isoproterenol during pregnancy.
Bronchospasm, throat irritation, bad taste, cough, wheezing, nasal congestion, anaphylaxis.
Formerly known under the brand name Intal.
Clinical Pain Advisor Articles
- Chronic Neuropathic Pain Updated Classification by IASP for ICD-11
- Buprenorphine-Naloxone Found to Be More Cost-Effective Than Extended-Release Naltrexone
- Ultrasound-Guided C2 Coblation May Be Effective for Cervicogenic Headache
- Meta-Analysis of Opioid Treatment for Chronic Noncancer Pain
- Opioids Found to Increase Risk for Community-Acquired Pneumonia, Particularly in HIV
- Reviewing the Use of Buprenorphine in Perioperative Pain Management
- Early Physical Therapy for Musculoskeletal Pain May Reduce Opioid Use
- External Trigeminal Nerve Stimulation May Alleviate Migraine Pain
- IASP Updates Diagnosis Criteria for Chronic Primary Pain for ICD-11
- Galcanezumab Provides Persistent Preventive Effects in Episodic, Chronic Migraine
- Comparable Analgesia With Low-Dose IV Ketamine, Morphine for Acute Pain
- Benzodiazepines, if Prescribed, May Not Affect Methadone Treatment Retention
- When Opioid Prescribing Guidelines Become Rules
- IV Fluid Confers No Significant Treatment Effect on Migraine Pain
- American Headache Society Releases Position Statement on Novel Preventive and Acute Migraine Treatments